Emdeon Inc. Acquires Chamberlin Edmonds & Associates, Inc.

We represented Emdeon Inc. in its $260 million acquisition of Chamberlin Edmonds & Associates, Inc., a provider of government program eligibility and enrollment services to acute care facilities.

Emdeon (formerly NYSE: EM) is a leading provider of revenue and payment cycle management and clinical information exchange solutions, connecting payers, providers and patients in the U.S. healthcare system.

As of December 2015, Emdeon was rebranded to Change Healthcare.

You Also May Be Interested In:

  • Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners

    We served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant...
    Client Type: Private Company
  • Representation of LogistiCare in its $80 million acquisition of National MedTrans, a single source Non-Emergency Medical Transportation (NEMT) benefit management company focused on delivering services to managed care organizations and governmental entities throughout the United States, as well as the extension of its revolving credit facilities from $200 million to $225 million

    We represented LogistiCare in its $80 million acquisition of National MedTrans, a single source Non-Emergency Medical Transportation (NEMT) benefit management...
    Client Type: Private Company
  • Representation of Spring Fertility, a leading provider of fertility care in Northern California backed by Wildcat Capital, in its acquisition of Genesis Fertility Centre, a Vancouver, British Columbia-based fertility clinic

    We represented Spring Fertility, a leading provider of fertility care in Northern California backed by Wildcat Capital, in its acquisition...
    Client Type: Private Company